Back
Waters Corp. 10K Form
Sell
49
WAT
Waters Corp.
Last Price:
$304.33
Seasonality Move:
5.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-27 | 10K | WAT/Waters Corp. Annual |
| 2023-02-27 | 10K | WAT/Waters Corp. Annual |
| 2022-02-24 | 10K | WAT/Waters Corp. Annual |
| 2021-02-24 | 10K | WAT/Waters Corp. Annual |
| 2020-02-25 | 10K | WAT/Waters Corp. Annual |
| 2019-03-01 | 10K | WAT/Waters Corp. Annual |
Receive WAT News And Ratings
See the #1 stock for the next 7 days that we like better than WAT
WAT Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $102.3M |
| Price / Cash Flow: | 35.68 |
| Annual Sales: | $43.01 |
| Price / Book: | 11.83 |
Profitability
| EPS (TTM): | 10.76500 |
|---|---|
| Net Income (TTM): | $642.6M |
| Gross Margin: | $1.8B |
| Return on Equity: | 29.63% |
| Return on Assets: | 13.5% |
Waters Corp. Earnings Forecast
Key Waters Corp. Financial Ratios
-
The Gross Profit Margin over the past 31 years for WAT is 57.83%.
-
The Selling, General & Administrative Expenses for WAT have been equal to 26.23% of Gross Profit Margin.
-
The Research & Development expenses have been 6.17% of Revenue.
-
The Interest Expense is 10.82% of Operating Income.
-
The Net Earning history of WAT is 20.30% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 22 years.
Waters Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | WAT |
| CUSIP: | 941848 |
| Website: | waters.com |
Debt
| Debt-to-Equity Ratio: | 0.58 |
|---|---|
| Current Ratio: | 1.73 |
| Quick Ratio: | 1.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.69 |
|---|---|
| Forward P/E Ratio: | 18.88 |
WAT Technical Analysis vs Fundamental Analysis
Sell
49
Waters Corp. (WAT)
is a Sell
Is Waters Corp. a Buy or a Sell?
-
Waters Corp. stock is rated a SellThe current Waters Corp. [WAT] share price is $304.24. The Score for WAT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.